This doctoral thesis addresses the implications of two health care innovations.
One in glaucoma care and one in chronic lymphocytic leukaemia. The implications are expressed in terms of costs and health effects.
Furthermore, in the case of one innovation, the implications of relations between professions are also discussed.

C.A. Uyl-de Groot (Carin) , M.A. Koopmanschap (Marc)
Erasmus University Rotterdam
The glaucoma study (chapters 2, 3 and 4) was funded by the Netherlands Organisation for Health Research and Development (ZonMw), grant number 945-04-457, and The Rotterdam Eye Hospital Research Foundation Prof.Dr H.J. Flieringa. The CLL study (chapters 5, 6 and 7) was financially supported through an unrestricted grant by Bayer Healthcare AG.
Erasmus School of Health Policy & Management (ESHPM)

Holtzer-Goor, K. (2015, November 12). Health technology assessment of health care innovations in chronic lymphocytic leukaemia and glaucoma care. Retrieved from